Patent Oppositions in antibodies industry

Explore the competitive field of antibodies where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in antibodies technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the antibodies industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the antibodies industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 16, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
PolypeptidesSORRISO PHARMACEUTICALSJun 10, 2026SANOFI
Antibody Producing Non-Human MammalsMERUSJun 3, 2026KYMAB
Neutralization Of Inhibitory Pathways In LymphocytesINNATE PHARMAMay 13, 2026STRAWMAN
Methods For Treating Nasal Polyposis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYMay 6, 2026ENGELHARD
Nemolizumab In The Treatment Of Atopic Dermatitis With Moderate To Severe ExcoriationGALDERMA HOLDINGApr 30, 2026CABINET BECKER ET ASSOCIES
Stable Antibody FormulationREGENERON PHARMACEUTICALSApr 23, 2026STRAWMAN
Compositions And Methods For Muscle Regeneration Using Prostaglandin E2THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYApr 22, 2026DORRIES
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEApr 16, 2026STORZ
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEApr 8, 2026BRAND MURRAY FULLER
Treatment Of Lung Cancer Using A Combination Of An Anti-Pd-1 Antibody And An Anti-Ctla-4 AntibodyBRISTOL MYERS SQUIBBMar 18, 2026POHLMAN

To stay ahead in the competitive antibodies industry, companies are constantly innovating. Here are the top patents facing oppositions in the antibodies industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 16, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS15
Jan 10, 2018Method To Improve Virus Removal In Protein PurificationF HOFFMANN LA ROCHE15
May 15, 2019Combination Therapy For The Treatment Of Ovarian CancerF HOFFMANN LA ROCHE12
Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB11
Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentSHIONOGI11
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLUDWIG MAXIMILIANS UNIVERSITT MNCHEN11
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALS10
May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHE9
May 1, 2019Combination Of Vaccination And Inhibition Of The Pd-1 PathwayCUREVAC8
May 26, 2021Hydrophobic Interaction Protein Chromatography Under No-Salt ConditionsBIOGEN MA8